alpha,beta-methyleneadenosine 5'-triphosphate has been researched along with nf 279 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rettinger, J; Schmalzing, G | 1 |
| Gordienko, DV; Harhun, MI; Povstyan, OV | 1 |
2 other study(ies) available for alpha,beta-methyleneadenosine 5'-triphosphate and nf 279
| Article | Year |
|---|---|
Desensitization masks nanomolar potency of ATP for the P2X1 receptor.
Topics: Adenosine Triphosphate; Affinity Labels; Animals; Binding, Competitive; Dose-Response Relationship, Drug; Electrophysiology; Kinetics; Models, Biological; Models, Chemical; Oocytes; Plasmids; Protein Binding; Receptors, Purinergic P2; Receptors, Purinergic P2X; Recombinant Fusion Proteins; Suramin; Thionucleotides; Time Factors; Xenopus | 2004 |
Purinoreceptor-mediated current in myocytes from renal resistance arteries.
Topics: Adenosine Triphosphate; Animals; Arteries; Kidney; Kinetics; Male; Membrane Potentials; Microdissection; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Organ Specificity; Osmolar Concentration; Patch-Clamp Techniques; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred WKY; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Suramin | 2010 |